title: [Results of surgical treatment for pulmonary aspergilloma with 26 cases in six years: a single center experience].
abstract: Surgery for pulmonary aspergilloma is reputed to be risky. We analyzed our results of the surgical treatment for pulmonary aspergilloma. Between 2003 and 2009, 26 patients underwent thoracotomy for treatment of pulmonary aspergilloma in our center. Results were evaluated retrospectively. There were 5 female and 21 male patients, with a mean age of 44 ± 11.6 years (28-70). The patients were divided into two groups, group A (simple aspergilloma; n= 8) and group B (complex aspergilloma; n= 18). Major underlying diseases were tuberculosis (61.5%). The most common indication for operation was hemoptysis (57.6%). Of our patients, 23% were complaining of massive hemoptysis or recurrent hemoptysis. Other patients were complaining of mild symptoms and some of them were totally asymptomatic. We performed 15 (57.6%) lobectomies (3 with associated segmentectomies), 8 (30.6%) segmentectomies/wedge resections, 2 (7.6%) pneumonectomies, and 1 (3.8%) cavernoplasty. Postoperative complications occurred in 15 (57.6%) patients. Complications occurred in 72.2% patients of complex aspergilloma, whereas 25% occurred in simple aspergilloma (p= 0.03). Major complications included prolonged air leak, empyema, air space. One patient who underwent lobectomies for complex aspergilloma developed bronchopleural fistula and died of respiratory failure on the 20th postoperative day. Operative mortality was 3.8%. The average postoperative hospital stay was 12.9 days. The mean follow-up period was average 44 months. The actuarial survival at 3 years was 90% and 100% for complex aspergilloma and simple aspergilloma, respectively (p> 0.05). There was two recurrence of disease (8%). But no recurrence of hemoptysis. Low morbidity rate may have been due to the selection of patients with localized pulmonary disease in this study. Surgical resection of asymptomatic or symptomatic pulmonary aspergilloma is effective in preventing recurrence or massive hemoptysis for patients whose condition is fit for pulmonary resection with reasonable mortality, morbidity and survival rates.
authors.affiliation: Clinic of 1st Chest Surgery, Yedikule Chest Diseases and Chest Surgery, Training and Research Hospital, Istanbul, Turkey. necomomus@mynet.com
authors.forename: Necati
authors.initials: N
authors.lastname: Citak
authors.forename: Adnan
authors.initials: A
authors.lastname: Sayar
authors.forename: Muzaffer
authors.initials: M
authors.lastname: Metin
authors.forename: Atilla
authors.initials: A
authors.lastname: Pekçolaklar
authors.forename: Abdulaziz
authors.initials: A
authors.lastname: Kök
authors.forename: Neslihan
authors.initials: N
authors.lastname: Akanıl Fener
authors.forename: Alper
authors.initials: A
authors.lastname: Celikten
authors.forename: Atilla
authors.initials: A
authors.lastname: Gürses
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006469:Hemoptysis; D006801:Humans; D008168:Lung / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy; D011183:Postoperative Complications / Q000453:epidemiology; D055732:Pulmonary Aspergillosis / Q000150:complications / Q000601:surgery*; D013510:Pulmonary Surgical Procedures; D012189:Retrospective Studies; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications